ZWI Therapeutics is a biotech company developing a new polymer to reduce immunogenicity and aid pharmacokinetics of protein therapeutics.
ZWI Therapeutics, Inc. has raised $10.0M in total funding. The most recent round was Series A. The last funding was announced in January 2024.
ZWI Therapeutics, Inc.'s investors include Sherpa Healthcare Partners, Co-win Healthcare Fund.
ZWI Therapeutics, Inc. is headquartered in Watertown, United States.
ZWI Therapeutics is a biotech company developing a new polymer to reduce immunogenicity and aid pharmacokinetics of protein therapeutics.
ZWI Therapeutics, Inc. is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ZWI Therapeutics, Inc. — Funding & Investors." VCBacked, January 24, 2024, https://www.vcbacked.co/company/zwi-therapeutics-inc. Accessed August 14, 2026.
VCBacked. (2024). ZWI Therapeutics, Inc. — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/zwi-therapeutics-inc
{{cite web |title=ZWI Therapeutics, Inc. — Funding & Investors |url=https://www.vcbacked.co/company/zwi-therapeutics-inc |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated